eHave Inc.

OTC: EHVVF

Company Logo

Company Overview

Ehave, Inc. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients.

The company's primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant. 

The company's main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. 

The Ehave dashboard offers Offline Encrypted Digital Records Empowering Healthcare providers and patients and it's a powerful machine learning and artificial intelligence platform using artificial intelligence to extract deep insights from audio, video and text to improve research with a growing set of advanced tools and applications developed by Ehave and its leading partners. 

This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools.

Financial Highlights

$0

Revenue (ttm)

-$32,300

Gross Profit (ttm)

-$0.17

Diluted EPS (ttm)

Management Team

Mr. Benjamin Kaplan
Chairman, Pres & CEO

Mr. Alfred Farrington II
Chief Information Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$927,465

Shares Outstanding
25,410,000

Shares Short (% of Float)
0 (0%)

Insider Ownership
71%